- Home
- » Tags
- » Nandrolone laurate
Top View
- Pharmaabkommen A1 E
- Ultra High Performance Liquid Chromatography/Tandem Mass
- Customs Tariff - Schedule Xxi - 1
- Distributeur Courtage Analyses Services 14 Rue De Mouettes 76130 Mont Saint Aignan Tel +33 (0) 2 35 07 60 00 Fax +33 (0)
- (12) Patent Application Publication (10) Pub. No.: US 2009/0163449 A1 Wempe (43) Pub
- Harmonized Tariff Schedule of the United States (2006) (Rev
- (12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
- (12) United States Patent (10) Patent No.: US 9,642,809 B2 Hemmingsen Et Al
- Summary of Product Characteristics 1. Name Of
- Pharmaceutical Reference Substances and Impurities
- Lot Lists of Pharmacopoeias EP, EPISA, ICRS, USP, BP March 2016
- Steroids,Sarms,Peptidesandapi Catalog
- Drugs and Related Substances
- Evidence-Based Clinical Question an Evidence-Based Analysis of Anabolic Steroids As Performance Enhancers in Horses S
- Pharma07catcr
- Sensitive and Robust Analysis of Anabolic Steroids, Steroid Esters and Other Banned Substances in Equine Plasma
- “The Manual” Preface
- Pharmacopoeial Reference Standards and Their Current Lot Numbers EP, EPISA, ICRS, BP
- LAURABOLIN® 25 Mg ANABOLIC STEROID for INTRAMUSCULAR OR SUBCUTANEOUS INJECTION
- Schedule Clxxiii - European Union
- Medicinal Products (Prescription and Control of Supply) Regulations 2003
- Nandrolone Undecylate (Rinnm) ⊗ Nandrolone Undecanoate (BANM); Nandrolone, Undécylate De; Endometriosis